Abstract 15785: Effects of Empagliflozin on Fatty Acid Binding Protein 4 and Body Composition in Patients Without Diabetes but With Risk Factors for Adverse Cardiac Remodeling From the Empa-Heart 2 Cardiolink-7 Randomized Clinical Trial
Authors: Ning-i Yang, Chao-Hung Wang, David Mazer, Subodh Verma
Published: 2023-12-19
DOI:
10.1161/circ.148.suppl_1.15785
Source:
Full article
Abstract
Background: